No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Genedrive revealed on Tuesday that chief executive Gino Miele had acquired 700,000 ordinary shares in the AIM-listed pharmacogenetic testing company.
Miele, who took over as CEO in August 2024, purchased the shares at an average price of 1.38p each, for a total value of £9,660.
Following the purchase, Miele holds a beneficial interest in 7.9m ordinary Genedrive shares, representing approximately 0.49% of the company's issued share capital.
As of 1415 BST, Genedrive shares were up 7.14% at 1.50p.
Reporting by Iain Gilbert at Sharecast.com
Top Director Buys
Staffline Group (STAF)
Director name: Spain,Thomas
Amount purchased: 75,249 @ 42.00p
Value: £31,604.58
Genedrive (GDR)
Director name: Miele,Gino
Amount purchased: 700,000 @ 1.38p
Value: £9,660.00
Invesco Bond Income Plus Limited Npv (BIPS)
Director name: Kumar ,Arun
Amount purchased: 2,757 @ 170.74p
Value: £4,707.30
Top Director Sells
Staffline Group (STAF)
Director name: Spain,Thomas
Amount sold: 75,249 @ 42.00p
Value: £31,604.58
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.